Chloé Antier

机构：Centre Hospitalier Universitaire de Nantes, Nantes Université · ORCID：0000-0001-6227-8540

发表论文 30 篇 · 总被引 164 次 · h-index 6

代表论文

• Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study (2021 · Blood Advances · 被引 51)
• High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma (2023 · Blood Advances · 被引 18)
• Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC (2023 · Transplantation and Cellular Therapy · 被引 10)
• Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia: Relapse Incidence, Characteristics, Role of Conditioning Regimen, and Outcome (2024 · Cancers · 被引 9)
• VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target (2025 · Leukemia · 被引 6)
• Phase I study of zoledronic acid combined with escalated doses of interleukine‐2 for early in vivo generation of Vγ9Vδ2 T ‐cells after haploidentical stem cell transplant with posttransplant cyclophosphamide (2024 · American Journal of Hematology · 被引 5)